NCT00955786View on ClinicalTrials.gov

Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

December 31, 2008

Conditions
Advanced Solid TumorsLymphoma
Interventions
DRUG

CX-3543

Escalating doses of CX-3543 administered intravenously daily for 5 consecutive days every 21 days.

Trial Locations (2)

78229

San Antonio

85259

Scottsdale

Sponsors
All Listed Sponsors
lead

Cylene Pharmaceuticals

INDUSTRY